Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology
Epilepsia · 2026
DOI: 10.1111/epi.18655 ↗At a glance
Multizentrische Studie in Epilepsia, 2026. Written by Simona Balestrini and 29 co-authors. Institution: Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy. Major MEDLINE topics: Epilepsy, Absence. Cited 6 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objective
To characterize the clinical, electroencephalographic, and genetic features of epilepsies featuring absence seizures within monogenic etiology, highlighting the diagnostic, treatment and prognostic implications.
Methods
We conducted a retrospective, multicenter study including patients with monogenic epilepsies and electroencephalography (EEG)–documented absence seizures. We analyzed clinical data, electroclinical findings, neurodevelopmental outcomes, and treatment responses through standardized questionnaires and medical records. We classified genetic variants according to American College of Medical Genetics and Genomics (ACMG) guidelines and performed univariate and multivariate analyses to identify predictors of developmental outcomes.
Results
We included 160 patients (111 female; median age at last follow‐up: 13 years) with absence seizures and confirmed pathogenic or likely pathogenic monogenic variants. The most frequently implicated genes were SLC2A1, SLC6A1, SYNGAP1 , CHD2, and SCN1A . Four genes— HESX1, NCKAP1, SON, STARD9 —had not been previously associated with absence seizures. In 35% of patients, absence seizures were the only seizure type and in 67% were the initial manifestation. Atypical features included irregular EEG discharges (56%) eyelid myoclonia (42%), and automatisms (33%). Early‐onset (before age 3) seizures occurred in 58% and was significantly associated with atypical features ( p < .03). Using existing International League Against Epilepsy (ILAE) epilepsy syndrome classification, 60% of patients could not be classified. Developmental delay occurred in 54%, intellectual disability in 65%, and other neurodevelopmental comorbidities in 49%. Predictors of poor developmental outcomes included early developmental delay, drug‐resistant epilepsy, and early absence onset. We found no difference in the prevalence of drug resistance across the various genetic etiologies. The most effective medications for absence seizures included valproate, ethosuximide, benzodiazepines, and lamotrigine. Disease‐specific therapies (e.g., ketogenic diet in SLC2A1 , stiripentol/fenfluramine in SCN1A) were effective in select cases. Significance Absence seizures are a common manifestation of different monogenic epilepsies, often associated with early onset, atypical clinical and/or EEG features, developmental delay or drug resistance. Classification models should incorporate genetic data alongside electroclinical features, especially as next‐generation sequencing is increasingly used.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy.
- Department of Neuroscience, Pharmacology and Child Health, University of Florence, Florence, Italy.
- Department of Women/Child Health and Urological Science, Sapienza University of Rome, Rome, Italy.
- Unit of Child Neurology and Psychiatry, Department of Neuroscience/Mental Health, Azienda Ospedaliero Universitaria Policlinico Umberto I- Rome, Rome, Italy.
- Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
- Paediatric Neurology and Psychiatry Unit, Spedali Civili Children's Hospital, University of Brescia, Brescia, Italy.
ORCID profiles: Simona Balestrini, Ilaria Galli, Maria Luisa Ricci, Elena Parrini, Davide Mei, Mario Mastrangelo, Francesco Pisani, Corinna Filippi, Lucio Giordano, Elisabetta Cesaroni, Carla Marini, Emanuele Cerulli Irelli, Carlo di Bonaventura, Marica Rubino, Antonietta Coppola, Jacopo Proietti, Tommaso Lo Barco, Francesca Darra, Laura Licchetta, Francesca Bisulli, Marco Perulli, Domenica Battaglia, Angela De Dominicis, Marina Trivisano, Nicola Specchio, Roberta Solazzi, Davide Caputo, Laura Canafoglia, Renzo Guerrini
Cite
APA
Balestrini, S., Galli, I., Ricci, M. L., Parrini, E., Mei, D., Mastrangelo, M., Pisani, F., Filippi, C., Giordano, L., Cesaroni, E., Marini, C., Cerulli Irelli, E., di Bonaventura, C., Rubino, M., Coppola, A., Proietti, J., Barco, T. L., Darra, F., Licchetta, L., …, & Guerrini, R. (2026). Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology. Epilepsia. https://doi.org/10.1111/epi.18655
Vancouver
Balestrini S, Galli I, Ricci ML, Parrini E, Mei D, Mastrangelo M, et al. Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology. Epilepsia. 2026. doi:10.1111/epi.18655
BibTeX
@article{Balestrini2026,
author = {Balestrini, Simona and Galli, Ilaria and Ricci, Maria Luisa and Parrini, Elena and Mei, Davide and Mastrangelo, Mario and Pisani, Francesco and Filippi, Corinna and Giordano, Lucio and Cesaroni, Elisabetta and Marini, Carla and Cerulli Irelli, Emanuele and di Bonaventura, Carlo and Rubino, Marica and Coppola, Antonietta and Proietti, Jacopo and Barco, Tommaso Lo and Darra, Francesca and Licchetta, Laura and Bisulli, Francesca and Perulli, Marco and Battaglia, Domenica and De Dominicis, Angela and Trivisano, Marina and Specchio, Nicola and Solazzi, Roberta and Caputo, Davide and Canafoglia, Laura and LICE Collaborative group, LICE Collaborative group and Guerrini, Renzo},
title = {Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology},
journal = {Epilepsia},
year = {2026},
doi = {10.1111/epi.18655}
}
EUVIMED